139264-24-7,
(4R)-4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one,
UNII-F3YOE57701,
F3YOE57701,
AscoTop,
Zolmitriptan R-isomer,
Zolmitriptan, (R)-,
(R)-4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)oxazolidin-2-one,
2-Oxazolidinone, 4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)-, (4R)-,
2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (4R)-,
Zomig Rapimelt,
Zolmitriptan R-isomer RS [USP],
AC1L9AT6,
SCHEMBL40595,
KSC521O1F,
OXA013,
ZINC5298,
CTK4C1712,
ZMT,
ANW-46071,
(R)-4-((3-(2-(Dimethylamino)ethyl)indol-5-yl(methyl)oxazolidin-2-one,
AKOS015895148,
RTC-070935,
AJ-08244,
AX8157418,
(4R)-4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one,
zolmitriptan,
Zomig,
Rapimelt,
Zomigoro,
Zomigon,
Flezol,
(R)-Zolmitriptan,
Zomig Nasal Spray,
Zomig ZMT,
Zomig-ZMT,
Zolmitriptan [USAN],
UNII-2FS66TH3YW,
139264-17-8,
Zolmitriptan [USAN:INN:BAN],
CID441240,
C16-H21-N3-O2,
311C90,
(S)-4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone,
4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone,
(4S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone,
(S)-N,N-Dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-ylmethyl)-1H-indol-3-yl]ethylamine,